Page last updated: 2024-08-24

cr 1392 and proglumide

cr 1392 has been researched along with proglumide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, S; Fujii, M; Fujisawa, T; Hasegawa, H; Koide, M; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S1
Baba, S; Fujii, M; Fujisawa, T; Itoh, H; Nakamura, T; Okabayshi, Y; Otsuki, M; Tani, S1
Baba, S; Fujii, M; Fujisawa, T; Koide, M; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S1
Allescher, HD; Daniel, EE; Fox, JE; Kostolanska, F; Rovati, LA1
Bani, M; Chisté, R; Makovec, F; Revel, L; Rovati, LA; Rovati, LC1
Nagy, I; Pap, A; Takács, T; Varró, V1
Tani, S1

Other Studies

7 other study(ies) available for cr 1392 and proglumide

ArticleYear
Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
    Pancreas, 1990, Volume: 5, Issue:3

    Topics: Animals; Cholecystokinin; Glutamine; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreas; Proglumide; Radioimmunoassay; Rats; Rats, Inbred Strains

1990
Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats.
    Pancreas, 1989, Volume: 4, Issue:2

    Topics: Acute Disease; Amylases; Animals; Ceruletide; Glutamine; Humans; Male; Organ Size; Pancreas; Pancreatitis; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin

1989
Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Digestion, 1989, Volume: 42, Issue:2

    Topics: Amylases; Animals; Cholecystokinin; Dose-Response Relationship, Drug; Glutamine; Male; Pancreas; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Sincalide

1989
Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 251, Issue:3

    Topics: Animals; Cholecystokinin; Dogs; Duodenum; Electric Stimulation; Female; Gastrointestinal Motility; Glutamine; Male; Proglumide; Pyloric Antrum; Pylorus; Receptors, Cholecystokinin; Tetrodotoxin

1989
Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:1

    Topics: Animals; Benzamides; Cerebral Cortex; In Vitro Techniques; Kinetics; Male; Mice; Pancreas; Proglumide; Rats; Receptors, Cell Surface; Receptors, Cholecystokinin; Sincalide; Tetragastrin

1986
The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
    Pancreas, 1988, Volume: 3, Issue:4

    Topics: Anesthesia; Animals; Cholecystokinin; Glutamine; Male; Pancreas; Proglumide; Rats; Rats, Inbred Strains

1988
Experimental acute pancreatitis induced by excessive doses of caerulein in rats; protective and therapeutic effects of trypsin inhibitor urinastatin and CCK receptor antagonist CR1392.
    The Kobe journal of medical sciences, 1988, Volume: 34, Issue:2

    Topics: Acute Disease; Animals; Ceruletide; Disease Models, Animal; Dose-Response Relationship, Drug; Glutamine; Glycoproteins; Kinetics; Male; Microscopy, Electron; Pancreatitis; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Trypsin Inhibitors

1988